The groups filing the suit are Pharmaceutical Research and Manufacturers of America, Partnership for Safe Medicines and the Council for Affordable Health Coverage.
President Donald Trump signed an executive order in July to allow states, wholesalers and pharmacies to import FDA-approved drugs from Canada and other countries where drug prices are significantly lower.
The groups argue that the final rule disregards key protections under the federal Food, Drug, and Cosmetic Act that ensure patient safety. The groups also say that there is no indication that the final rule would reduce costs to patients.
“The bottom line is that the administration has violated federal law by proceeding without proper certification and, in doing so, is putting the health and safety of Americans in jeopardy,” said PhRMA Executive Vice President and General Counsel James Stansel.
More articles on pharmacy:
CVS Pharmacy taps new president, Neela Montgomery
White House releases 2 new drug-pricing rules
Merck to acquire COVID-19 drug developer for $425M
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
